JESSICA LOCKE: Open Payments
NPI 1396452884 · LEBANON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 31 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $113 |
| Lilly USA, LLC | 5 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $43 |
| Alkermes, Inc. | 2 | $34 |
| Radius Health, Inc. | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: QULIPTA, KISUNLA, CAPLYTA, FANAPT, ARISTADA, Tymlos, INGREZZA, Ozempic.
Industry payments across MO — which companies pay providers there.
